Literature DB >> 17693766

Renal physiology of SLC26 anion exchangers.

Aleksandra Sindić1, Min-Hwang Chang, David B Mount, Michael F Romero.   

Abstract

PURPOSE OF REVIEW: The multifunctional anion exchanger family (Slc26) encompasses 11 identified genes, but only 10 encode real proteins (Slc26a10 is a pseudogene). Most of the Slc26 proteins function primarily as anion exchangers, exchanging sulfate, iodide, formate, oxalate, hydroxyl ion, and bicarbonate anions, whereas other Slc26 proteins function as chloride ion channels or anion-gated molecular motors. The aim of this review is to present recent studies on the molecular function of the Slc26 family and its role in renal physiology and pathophysiology. RECENT
FINDINGS: In proximal tubules, Slc26a1 (Sat-1) mediates sulfate and oxalate transport across the basolateral membrane, while Slc26a6 (CFEX, Pat-1) mediates a variety of anion exchange at the apical membrane to facilitate transcellular sodium chloride absorption. Targeted deletion of murine Slc26a6 leads to intestinal hyperabsorption of oxalate, hyperoxaluria, and kidney stones. Slc26a4 (pendrin) and Slc26a7 are expressed in intercalated cells, and are involved in acid-base homeostasis and blood pressure regulation. Messenger RNA for Slc26a2, Slc26a9, and Slc26a11 is also present in the kidney, yet the roles of these family members in renal physiology or pathophysiology are not clear.
SUMMARY: Members of this multifunctional anion transporter family play evolving roles in the etiology of nephrolithiasis (Slc26a6) and hypertension (Slc26a4 and Slc26a6). Other Slc26 family members (Slc26a2, Slc26a9, Slc26a11) express mRNA in the kidney but their roles in renal physiology are not yet known.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693766     DOI: 10.1097/MNH.0b013e3282e7d7d0

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  28 in total

1.  The role of SLC26A6-mediated chloride/oxalate exchange in causing susceptibility to nephrolithiasis.

Authors:  Manoocher Soleimani
Journal:  J Physiol       Date:  2008-03-01       Impact factor: 5.182

Review 2.  Diverse transport modes by the solute carrier 26 family of anion transporters.

Authors:  Ehud Ohana; Dongki Yang; Nikolay Shcheynikov; Shmuel Muallem
Journal:  J Physiol       Date:  2008-11-17       Impact factor: 5.182

Review 3.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 4.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis.

Authors:  Salma Sohrabi-Jahromi; Sayed-Amir Marashi; Shiva Kalantari
Journal:  Mamm Genome       Date:  2016-02-29       Impact factor: 2.957

6.  Sodium-bicarbonate cotransporter NBCn1/Slc4a7 inhibits NH4Cl-mediated inward current in Xenopus oocytes.

Authors:  Soojung Lee; Inyeong Choi
Journal:  Exp Physiol       Date:  2011-05-13       Impact factor: 2.969

7.  Slc26a3/Dra and Slc26a6 in Murine Ameloblasts.

Authors:  R Jalali; B Zandieh-Doulabi; P K DenBesten; U Seidler; B Riederer; S Wedenoja; D Micha; A L J J Bronckers
Journal:  J Dent Res       Date:  2015-09-22       Impact factor: 6.116

Review 8.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

Review 9.  The regulation of proximal tubular salt transport in hypertension: an update.

Authors:  Xiaoyan Wang; Ines Armando; Kiran Upadhyay; Annabelle Pascua; Pedro A Jose
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894

10.  Analysis and update of the human solute carrier (SLC) gene superfamily.

Authors:  Lei He; Konstandinos Vasiliou; Daniel W Nebert
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.